Insulin-like growth factor 1 (IGF-1) and Hepatitis B protein, HBx, could enhance STAT5b signalling, leading to the increased migratory and invasive capabilities of HCC cells by promoting EMT [78,79]. Here, STAT5B is linked to hepatocellular carcinoma.